Checkpoint inhibitor induced myositis - The value of MRI STIR

Mai Erritzøe-Jervild; David Scheie; Christian Stenør

doi:10.1016/j.ensci.2022.100442

Checkpoint inhibitor induced myositis - The value of MRI STIR

eNeurologicalSci. 2023 Jan 4:30:100442. doi: 10.1016/j.ensci.2022.100442. eCollection 2023 Mar.

Authors

Mai Erritzøe-Jervild¹, David Scheie², Christian Stenør¹

Affiliations

¹ Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
² Department of Pathology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

Abstract

•Treatment with immune checkpoint inhibitors can cause serious adverse events.•Myositis combined with myocarditis ad adverse event have a mortality for 50%.•Early diagnosis is important for better outcome.•Employing MRI STIR can rapidly diagnose, guide biopsy, and classify cases of immune-related myositis.

Publication types

Case Reports